表紙:ヒトマイクロバイオーム治療薬の市場シェア、規模および動向:製品、治療部位、適応症、アプローチ、地域別のセグメント予測(2020年~2027年)
市場調査レポート
商品コード
953084

ヒトマイクロバイオーム治療薬の市場シェア、規模および動向:製品、治療部位、適応症、アプローチ、地域別のセグメント予測(2020年~2027年)

Human Microbiome Therapeutics Market Share, Size, Trends, Industry Analysis Report, By Product, By Therapeutic Area, By Indication, By Approach, By Regions, Segment Forecast, 2020 -2027

出版日: | 発行: Polaris Market Research | ページ情報: 英文 113 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=115.27円
ヒトマイクロバイオーム治療薬の市場シェア、規模および動向:製品、治療部位、適応症、アプローチ、地域別のセグメント予測(2020年~2027年)
出版日: 2020年07月01日
発行: Polaris Market Research
ページ情報: 英文 113 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のヒトマイクロバイオーム治療薬の市場規模は、2027年までに15億4,460万米ドルに達すると予測されています。同市場の成長を牽引する要因には、マイクロバイオームに基づく疾患の早期診断への注目度の高まり、腸内菌共生バランス失調による疾患有病率の増加、共同研究の増加、政府が支援する強力な資金提供を受けたマイクロバイオーム研究プロジェクトなどが挙げられます。2019年11月には、フランス、デンマーク、中国、ラトビア、スウェーデンなどと共同でメタゲノム研究を行う「Million Microbiome of Humans Project(MMHP)」が発足しました。今後数年間で、生殖管、腸、皮膚などから集められた100万以上のサンプルを分析して、最大のヒトマイクロバイオームデータベースを作成することを目的としています。

当レポートは、世界のヒトマイクロバイオーム治療薬市場について調査しており、市場機会や課題、成長および抑制要因、業界動向、製品・治療部位・適応症・アプローチ・地域別の市場分析、競合情勢、主要企業のプロファイル等の情報を提供しています。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

  • 市場ハイライト

第3章 調査手法

第4章 市場の洞察

  • 業界のスナップショット
  • 市場力学
    • 成長要因と機会
    • 抑制要因と課題
  • ポーターのファイブフォース分析
  • PESTLE分析
  • 業界動向

第5章 市場評価:製品別

  • 主な調査結果
  • イントロダクション
  • プロバイオティクス
  • プレバイオティクス
  • 医療食品
  • 処方薬

第6章 市場評価:治療部位別

  • 主な調査結果
  • イントロダクション
    • 世界市場:売上(2015-2026)
  • 自己免疫疾患
  • 歯科疾患
  • 消化器・胃腸障害
  • 皮膚疾患
  • 感染症
  • 代謝障害
  • 腫瘍学
  • その他

第7章 市場評価:適応症別

  • 主な調査結果
  • イントロダクション
    • 世界市場:売上(2015-2026)
  • 尋常性ざ瘡
  • アトピー性皮膚炎
  • クロストリジウムディフィシル感染症
  • 大腸がん
  • 糖尿病
  • 炎症性腸疾患(IBD)
  • 乳糖不耐症
  • 肺癌
  • 非アルコール性脂肪性肝炎(NASH)
  • 肥満
  • セリアック病

第8章 市場評価:アプローチ別

  • 主な調査結果
  • イントロダクション
    • 世界市場:売上(2015-2026)
  • 小分子療法
  • 単一菌株全細菌
  • 微生物コンソーシアム
  • 遺伝子組み換え単一菌株
  • ファージカクテル
  • 微生物エコシステム

第9章 市場の評価:地域別

  • 主な調査結果
  • イントロダクション
    • 市場評価:売上(2016-2027)
  • 北米
  • 欧州
  • アジア太平洋地域
  • 中東・アフリカ
  • ラテンアメリカ

第10章 競合情勢

  • 拡張と獲得の分析
    • 膨張分析
    • 獲得分析
  • 提携/協業/契約/公開

第11章 企業プロファイル

  • Enterome Bioscience
  • Seres Therapeutics
  • 4D Pharma PLC
  • Finch Therapeutics
  • GNUbiotics Sciences
  • 5QBD-Biotech
  • Vedanta Biosciences
  • Ferring Pharmaceuticals
  • Evelo Biosciences
  • Igen Biolab Group
  • Embion Technologies
図表

List of Tables

  • Table 1 Global Human Microbiome Therapeutics Market, By Product, 2016 - 2027 (USD Million)
  • Table 2 Global Human Microbiome Therapeutics Market, by Therapeutic Area, by Region, 2016-2027 (USD Million)
  • Table 3 Global Human Microbiome Therapeutics Market, by Indication, by Region, 2016-2027 (USD Million)
  • Table 4 Global Human Microbiome Therapeutics Market, by Approach, by Region, 2016-2027 (USD Million)
  • Table 5 Human Microbiome Therapeutics Market Assessment, By Geography, 2016-2027 (USD Million)
  • Table 6 North America: Human Microbiome Therapeutics Market, By Product Type, 2016-2027 (USD Million)
  • Table 7 North America: Human Microbiome Therapeutics Market, By Therapeutic Area, 2016-2027 (USD Million)
  • Table 8 North America: Human Microbiome Therapeutics Market, By Indication, 2016-2027 (USD Million)
  • Table 9 North America: Human Microbiome Therapeutics Market, By Approach, 2016-2027 (USD Million)
  • Table 10 U.S.: Human Microbiome Therapeutics Market, By Product Type, 2016-2027 (USD Million)
  • Table 11 U.S.: Human Microbiome Therapeutics Market, By Therapeutic Area, 2016-2027 (USD Million)
  • Table 12 U.S.: Human Microbiome Therapeutics Market, By Indication, 2016-2027 (USD Million)
  • Table 13 U.S.: Human Microbiome Therapeutics Market, By Approach, 2016-2027 (USD Million)
  • Table 14 Canada: Human Microbiome Therapeutics Market, By Product Type, 2016-2027 (USD Million)
  • Table 15 Canada: Human Microbiome Therapeutics Market, By Therapeutic Area, 2016-2027 (USD Million)
  • Table 16 Canada: Human Microbiome Therapeutics Market, By Indication, 2016-2027 (USD Million)
  • Table 17 Canada: Human Microbiome Therapeutics Market, By Approach, 2016-2027 (USD Million)
  • Table 18 Europe: Human Microbiome Therapeutics Market, By Product Type, 2016-2027 (USD Million)
  • Table 19 Europe: Human Microbiome Therapeutics Market, By Therapeutic Area, 2016-2027 (USD Million)
  • Table 20 Europe: Human Microbiome Therapeutics Market, By Indication, 2016-2027 (USD Million)
  • Table 21 Europe: Human Microbiome Therapeutics Market, By Approach, 2016-2027 (USD Million)
  • Table 22 UK: Human Microbiome Therapeutics Market, By Product Type, 2016-2027 (USD Million)
  • Table 23 UK: Human Microbiome Therapeutics Market, By Therapeutic Area, 2016-2027 (USD Million)
  • Table 24 UK: Human Microbiome Therapeutics Market, By Indication, 2016-2027 (USD Million)
  • Table 25 UK: Human Microbiome Therapeutics Market, By Approach, 2016-2027 (USD Million)
  • Table 26 France: Human Microbiome Therapeutics Market, By Product Type, 2016-2027 (USD Million)
  • Table 27 France: Human Microbiome Therapeutics Market, By Therapeutic Area, 2016-2027 (USD Million)
  • Table 28 France: Human Microbiome Therapeutics Market, By Indication, 2016-2027 (USD Million)
  • Table 29 France: Human Microbiome Therapeutics Market, By Approach, 2016-2027 (USD Million)
  • Table 30 Germany: Human Microbiome Therapeutics Market, By Product Type, 2016-2027 (USD Million)
  • Table 31 Germany: Human Microbiome Therapeutics Market, By Therapeutic Area, 2016-2027 (USD Million)
  • Table 32 Germany: Human Microbiome Therapeutics Market, By Indication, 2016-2027 (USD Million)
  • Table 33 Germany: Human Microbiome Therapeutics Market, By Approach, 2016-2027 (USD Million)
  • Table 34 Italy: Human Microbiome Therapeutics Market, By Product Type, 2016-2027 (USD Million)
  • Table 35 Italy: Human Microbiome Therapeutics Market, By Therapeutic Area, 2016-2027 (USD Million)
  • Table 36 Italy: Human Microbiome Therapeutics Market, By Indication, 2016-2027 (USD Million)
  • Table 37 Italy: Human Microbiome Therapeutics Market, By Approach, 2016-2027 (USD Million)
  • Table 38 Spain: Human Microbiome Therapeutics Market, By Product Type, 2016-2027 (USD Million)
  • Table 39 Spain: Human Microbiome Therapeutics Market, By Therapeutic Area, 2016-2027 (USD Million)
  • Table 40 Spain: Human Microbiome Therapeutics Market, By Indication, 2016-2027 (USD Million)
  • Table 41 Spain: Human Microbiome Therapeutics Market, By Approach, 2016-2027 (USD Million)
  • Table 42 Austria: Human Microbiome Therapeutics Market, By Product Type, 2016-2027 (USD Million)
  • Table 43 Austria: Human Microbiome Therapeutics Market, By Therapeutic Area, 2016-2027 (USD Million)
  • Table 44 Austria: Human Microbiome Therapeutics Market, By Indication, 2016-2027 (USD Million)
  • Table 45 Austria: Human Microbiome Therapeutics Market, By Approach, 2016-2027 (USD Million)
  • Table 46 Asia Pacific: Human Microbiome Therapeutics Market, By Product Type, 2016-2027 (USD Million)
  • Table 47 Asia Pacific: Human Microbiome Therapeutics Market, By Therapeutic Area, 2016-2027 (USD Million)
  • Table 48 Asia Pacific: Human Microbiome Therapeutics Market, By Indication, 2016-2027 (USD Million)
  • Table 49 Asia Pacific: Human Microbiome Therapeutics Market, By Approach, 2016-2027 (USD Million)
  • Table 50 China: Human Microbiome Therapeutics Market, By Product Type, 2016-2027 (USD Million)
  • Table 51 China: Human Microbiome Therapeutics Market, By Therapeutic Area, 2016-2027 (USD Million)
  • Table 52 China: Human Microbiome Therapeutics Market, By Indication, 2016-2027 (USD Million)
  • Table 53 China: Human Microbiome Therapeutics Market, By Approach, 2016-2027 (USD Million)
  • Table 54 India: Human Microbiome Therapeutics Market, By Product Type, 2016-2027 (USD Million)
  • Table 55 India: Human Microbiome Therapeutics Market, By Therapeutic Area, 2016-2027 (USD Million)
  • Table 56 India: Human Microbiome Therapeutics Market, By Indication, 2016-2027 (USD Million)
  • Table 57 India: Human Microbiome Therapeutics Market, By Approach, 2016-2027 (USD Million)
  • Table 58 Japan: Human Microbiome Therapeutics Market, By Product Type, 2016-2027 (USD Million)
  • Table 59 Japan: Human Microbiome Therapeutics Market, By Therapeutic Area, 2016-2027 (USD Million)
  • Table 60 Japan: Human Microbiome Therapeutics Market, By Indication, 2016-2027 (USD Million)
  • Table 61 Japan: Human Microbiome Therapeutics Market, By Approach, 2016-2027 (USD Million)
  • Table 62 Malaysia: Human Microbiome Therapeutics Market, By Product Type, 2016-2027 (USD Million)
  • Table 63 Malaysia: Human Microbiome Therapeutics Market, By Therapeutic Area, 2016-2027 (USD Million)
  • Table 64 Malaysia: Human Microbiome Therapeutics Market, By Indication, 2016-2027 (USD Million)
  • Table 65 Malaysia: Human Microbiome Therapeutics Market, By Approach, 2016-2027 (USD Million)
  • Table 66 South Korea: Human Microbiome Therapeutics Market, By Product Type, 2016-2027 (USD Million)
  • Table 67 South Korea: Human Microbiome Therapeutics Market, By Therapeutic Area, 2016-2027 (USD Million)
  • Table 68 South Korea: Human Microbiome Therapeutics Market, By Indication, 2016-2027 (USD Million)
  • Table 69 South Korea: Human Microbiome Therapeutics Market, By Approach, 2016-2027 (USD Million)
  • Table 70 Australia: Human Microbiome Therapeutics Market, By Product Type, 2016-2027 (USD Million)
  • Table 71 Australia: Human Microbiome Therapeutics Market, By Therapeutic Area, 2016-2027 (USD Million)
  • Table 72 Australia: Human Microbiome Therapeutics Market, By Indication, 2016-2027 (USD Million)
  • Table 73 Australia: Human Microbiome Therapeutics Market, By Approach, 2016-2027 (USD Million)
  • Table 74 Middle East & Africa: Human Microbiome Therapeutics Market, By Product Type, 2016-2027 (USD Million)
  • Table 75 Middle East & Africa: Human Microbiome Therapeutics Market, By Therapeutic Area, 2016-2027 (USD Million)
  • Table 76 Middle East & Africa: Human Microbiome Therapeutics Market, By Indication, 2016-2027 (USD Million)
  • Table 77 Middle East & Africa: Human Microbiome Therapeutics Market, By Approach, 2016-2027 (USD Million)
  • Table 78 Saudi Arabia: Human Microbiome Therapeutics Market, By Product Type, 2016-2027 (USD Million)
  • Table 79 Saudi Arabia: Human Microbiome Therapeutics Market, By Therapeutic Area, 2016-2027 (USD Million)
  • Table 80 Saudi Arabia: Human Microbiome Therapeutics Market, By Indication, 2016-2027 (USD Million)
  • Table 81 Saudi Arabia: Human Microbiome Therapeutics Market, By Approach, 2016-2027 (USD Million)
  • Table 82 Israel: Human Microbiome Therapeutics Market, By Product Type, 2016-2027 (USD Million)
  • Table 83 Israel: Human Microbiome Therapeutics Market, By Therapeutic Area, 2016-2027 (USD Million)
  • Table 84 Israel: Human Microbiome Therapeutics Market, By Indication, 2016-2027 (USD Million)
  • Table 85 Israel: Human Microbiome Therapeutics Market, By Approach, 2016-2027 (USD Million)
  • Table 86 South Africa: Human Microbiome Therapeutics Market, By Product Type, 2016-2027 (USD Million)
  • Table 87 South Africa: Human Microbiome Therapeutics Market, By Therapeutic Area, 2016-2027 (USD Million)
  • Table 88 South Africa: Human Microbiome Therapeutics Market, By Indication, 2016-2027 (USD Million)
  • Table 89 South Africa: Human Microbiome Therapeutics Market, By Approach, 2016-2027 (USD Million)
  • Table 90 Latin America: Human Microbiome Therapeutics Market, By Product Type, 2016-2027 (USD Million)
  • Table 91 Latin America: Human Microbiome Therapeutics Market, By Therapeutic Area, 2016-2027 (USD Million)
  • Table 92 Latin America: Human Microbiome Therapeutics Market, By Indication, 2016-2027 (USD Million)
  • Table 93 Latin America: Human Microbiome Therapeutics Market, By Approach, 2016-2027 (USD Million)
  • Table 94 Brazil: Human Microbiome Therapeutics Market, By Product Type, 2016-2027 (USD Million)
  • Table 95 Brazil: Human Microbiome Therapeutics Market, By Therapeutic Area, 2016-2027 (USD Million)
  • Table 96 Brazil: Human Microbiome Therapeutics Market, By Indication, 2016-2027 (USD Million)
  • Table 97 Brazil: Human Microbiome Therapeutics Market, By Approach, 2016-2027 (USD Million)
  • Table 98 Mexico: Human Microbiome Therapeutics Market, By Product Type, 2016-2027 (USD Million)
  • Table 99 Mexico: Human Microbiome Therapeutics Market, By Therapeutic Area, 2016-2027 (USD Million)
  • Table 100 Mexico: Human Microbiome Therapeutics Market, By Indication, 2016-2027 (USD Million)
  • Table 101 Mexico: Human Microbiome Therapeutics Market, By Approach, 2016-2027 (USD Million)
  • Table 102 Argentina: Human Microbiome Therapeutics Market, By Product Type, 2016-2027 (USD Million)
  • Table 103 Argentina: Human Microbiome Therapeutics Market, By Therapeutic Area, 2016-2027 (USD Million)
  • Table 104 Argentina: Human Microbiome Therapeutics Market, By Indication, 2016-2027 (USD Million)
  • Table 105 Argentina: Human Microbiome Therapeutics Market, By Approach, 2016-2027 (USD Million)

List of Figures

  • Figure 1. Market Highlights (2019, Revenue)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top Down & Bottom Up Approach
  • Figure 4. Market by Geography
  • Figure 6. Porter's Five Forces
  • Figure 7. Market by Product
  • Figure 8. Global Human Microbiome Therapeutics Market, By Product, 2019 & 2026 (USD Million)
  • Figure 9. Market by Therapeutic Area
  • Figure 8. Global Human Microbiome Therapeutics Market, By Therapeutic Area, 2019 & 2026 (USD Million)
  • Figure 9. Market by Indication
  • Figure 10. Global Human Microbiome Therapeutics Market, By Indication, 2019 & 2026 (USD Million)
  • Figure 11. Market by Approach
  • Figure 12. Global Human Microbiome Therapeutics Market, By Approach, 2019 & 2026 (USD Million)
  • Figure 13. Human Microbiome Therapeutics Market Assessment, By Geography, 2016-2027 (USD Million)
  • Figure 14. Strategic Analysis - Human Microbiome Therapeutics Market
目次
Product Code: PM1687

Title:
Human Microbiome Therapeutics Market Share, Size, Trends, Industry Analysis Report, By Product (Probiotics, Prebiotics, Medical Foods, and Prescription Drugs); By Therapeutic Area (Autoimmune Disorders, Dental Disorders, Digestive and Gastrointestinal Disorders, Dermatological Disorders, Infectious Disease, Metabolic Disorders, Oncology, and Others); By Indication; By Approach; By Regions; Segment Forecast, 2020 -2027.

The global human microbiome therapeutics market size is expected to reach USD 1,544.6 million by 2027 according to a new study by Polaris Market Research. The report "Human Microbiome Therapeutics Market Share, Size, Trends, Industry Analysis Report, By Product (Probiotics, Prebiotics, Medical Foods, and Prescription Drugs); By Therapeutic Area (Autoimmune Disorders, Dental Disorders, Digestive and Gastrointestinal Disorders, Dermatological Disorders, Infectious Disease, Metabolic Disorders, Oncology, and Others); By Indication (Acne Vulgaris, Atopic Dermatitis, Clostridium difficile Infection, Colorectal Cancer, Diabetes, Inflammatory Bowel Disease (IBD), Lactose Intolerance, Lung Cancer, Non-alcoholic steatohepatitis (NASH), Obesity, and Coeliac Disease); By Approach (Small Molecule Therapies, Single Strain Whole Bacteria, Microbial Consortia, Genetically Modified Single Strain Bacteria, Phage Cocktail, and Microbial Ecosystems), By Regions; Segment Forecast, 2020 -2027" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Microbiome refers to the residing micro-organisms genomes in the human body, particularly in the gut. The human body comprises more than 100 trillion microbes and around 2 million microbe genomes. These microbiota plays a significant role in the body's physiological functions and includes viruses, bacteria, and fungi. Primarily it has Bacteroidetes (gram negative) and Firmicutes, commonly Clostridium and Lactobacillus sp. (gram positive). The majority of these are strict anaerobes, with fungi and archaebacteria comprising less than 1 per cent of the total population.

The global market is driven by an increased focus on microbiome based early diagnosis of diseases, increase in the prevalence of diseases due to dysbiosis, rising collaborations, and strongly funded government backed microbiome research projects. In November 2019, the Million Microbiome of Humans Project (MMHP) was launched in collaboration with France, Denmark, China, Latvia, Sweden and other countries to co-operate in meta-genomic research. The aim is to create the largest human microbiome database from analyzing more than one million samples gathered from reproductive tract, gut, skin, and other organs in the next few years.

Market participants such as Enterome Bioscience, Biotagenics, Seres Therapeutics, Oxidien Pharmaceuticals, LLC, BoobyBiome, 4D Pharma PLC, UBiome, Carbiotix, E.I. du Pont de Nemours and Company, Finch Therapeutics, GNUbiotics Sciences, ClearB Therapeutics, GoodBelly, GoodGut, Synlogic, Second Genome, 16S Technologies, 5QBD-Biotech, Vedanta Biosciences, Holobiome, Commense, Ferring Pharmaceuticals, Evelo Biosciences, CoreBiome, Igen Biolab Group, ViThera Pharmaceuticals, DermBiont, Hyggut, Embion Technologies, Lactobio, BiomX, Exeliom Biosciences, and LNC Therapeutics are some of the key players operating in the concerned market.

Recently, in July 2020, 4D pharma plc., the UK based pharma company engaged in the development of live bio-therapeutics announced that patient enrollment for its phase II trial of its candidate oral immune-modulator MRx-4DP0004 for patients hospitalized with COVID-19 is open, and dosing to start very soon. The company is world leader in the production of live bio-therapeutics (live microbiome used to cure disease). Its products are the orally delivered single strain bacteria, which are naturally present in the human gut.

Polaris Market research has segmented the Human Microbiome Therapeutics market report on the basis of product, therapeutic area, indication, approach, and region

Human Microbiome Therapeutics Product Outlook (Revenue - USD Million, 2016 - 2027)

Probiotics

Prebiotics

Medical Foods

Prescription Drugs

Human Microbiome Therapeutic Area Outlook (Revenue - USD Million, 2016 - 2027)

Autoimmune Disorders

Dental Disorders

Digestive and Gastrointestinal Disorders

Dermatological Disorders

Infectious Disease

Metabolic Disorders

Oncology

Others

Human Microbiome Therapeutics Indication Outlook (Revenue - USD Million, 2016 - 2027)

Acne Vulgaris

Atopic Dermatitis

Clostridium Difficile Infection

Colorectal Cancer

Diabetes

Inflammatory Bowel Disease (IBD)

Lactose Intolerance

Lung Cancer

Non-alcoholic steatohepatitis (NASH)

Obesity

Coeliac Disease

Human Microbiome Therapeutics Approach Outlook (Revenue - USD Million, 2016 - 2027)

Small Molecule Therapies

Single Strain Whole Bacteria

Microbial Consortia

Genetically Modified Single Strain Bacteria

Phage Cocktail

Microbial Ecosystems

Human Microbiome Therapeutics Regional Outlook (Revenue - USD Million, 2016 - 2027)

North America

U.S.

Canada

Europe

France

Germany

UK

Italy

Netherlands

Spain

Austria

Asia Pacific

China

India

Japan

Malaysia

Australia

South Korea

Central & South America

Mexico

Brazil

Argentina

Middle East & Africa

UAE

Saudi Arabia

Israel

South Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Human Microbiome Therapeutics Market Insights

  • 4.1. Human Microbiome Therapeutics - Industry snapshot
  • 4.2. Human Microbiome Therapeutics Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Surge in the infectious diseases
      • 4.2.1.2. Government backed funding
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Side effects associated with the usage of biotherapeutics
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTLE Analysis
  • 4.5. Human Microbiome Therapeutics Market Industry trends

5. Human Microbiome Therapeutics Market Assessment by Product

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Human Microbiome Therapeutics Market, By Product, 2015 - 2026 (USD Million)
  • 5.3. Probiotics
    • 5.3.1. Global Human Microbiome Therapeutics Market, by Probiotics, by Region, 2016- 2027 (USD Million)
  • 5.4. Prebiotics
    • 5.4.1. Global Human Microbiome Therapeutics Market, by Prebiotics, by Region, 2016- 2027 (USD Million)
  • 5.5. Medical Foods
    • 5.5.1. Global Human Microbiome Therapeutics Market, by Medical Foods, by Region, 2016- 2027 (USD Million)
  • 5.6. Prescription Drugs
    • 5.6.1. Global Human Microbiome Therapeutics Market, by Prescription Drugs, by Region, 2016- 2027 (USD Million)

6. Global Human Microbiome Therapeutics Market, by Therapeutic Area

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Human Microbiome Therapeutics Market, By Therapeutic Area, 2015 - 2026 (USD Million)
  • 6.3. Autoimmune Disorders
    • 6.3.1. Global Human Microbiome Therapeutics Market, by Autoimmune Disorders, By Region, 2016- 2027 (USD Million)
  • 6.4. Dental Disorders
    • 6.4.1. Global Human Microbiome Therapeutics Market, by Dental Disorders, by Region, 2016- 2027 (USD Million)
  • 6.5. Digestive and Gastrointestinal Disorders
    • 6.5.1. Global Human Microbiome Therapeutics Market, by Digestive and Gastrointestinal Disorders, by Region, 2016- 2027 (USD Million)
  • 6.6. Dermatological Disorders
    • 6.6.1. Global Human Microbiome Therapeutics Market, by Dermatological Disorders, by Region, 2016- 2027 (USD Million)
  • 6.7. Infectious Disease
    • 6.7.1. Global Human Microbiome Therapeutics Market, by Infectious Disease, by Region, 2016- 2027 (USD Million)
  • 6.8. Metabolic Disorders
    • 6.8.1. Global Human Microbiome Therapeutics Market, by Metabolic Disorders, by Region, 2016- 2027 (USD Million)
  • 6.9. Oncology
    • 6.9.1. Global Human Microbiome Therapeutics Market, by Oncology, by Region, 2016- 2027 (USD Million)
  • 6.10. Others
    • 6.10.1. Global Human Microbiome Therapeutics Market, by Others, by Region, 2016- 2027 (USD Million)

7. Global Human Microbiome Therapeutics Market, by Indication

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Human Microbiome Therapeutics Market, By Indication, 2015 - 2026 (USD Million)
  • 7.3. Acne Vulgaris
    • 7.3.1. Global Human Microbiome Therapeutics Market, by Acne Vulgaris, By Region, 2016- 2027 (USD Million)
  • 7.4. Atopic Dermatitis
    • 7.4.1. Global Human Microbiome Therapeutics Market, by Atopic Dermatitis, by Region, 2016- 2027 (USD Million)
  • 7.5. Clostridium difficile Infection
    • 7.5.1. Global Human Microbiome Therapeutics Market, by Clostridium difficile Infection, by Region, 2016- 2027 (USD Million)
  • 7.6. Colorectal Cancer
    • 7.6.1. Global Human Microbiome Therapeutics Market, by Colorectal Cancer, by Region, 2016- 2027 (USD Million)
  • 7.7. Diabetes
    • 7.7.1. Global Human Microbiome Therapeutics Market, by Diabetes, by Region, 2016- 2027 (USD Million)
  • 7.8. Inflammatory Bowel Disease (IBD)
    • 7.8.1. Global Human Microbiome Therapeutics Market, by Inflammatory Bowel Disease (IBD), by Region, 2016- 2027 (USD Million)
  • 7.9. Lactose Intolerance
    • 7.9.1. Global Human Microbiome Therapeutics Market, by Lactose Intolerance, by Region, 2016- 2027 (USD Million)
  • 7.10. Lung Cancer
    • 7.10.1. Global Human Microbiome Therapeutics Market, by Lung Cancer, by Region, 2016- 2027 (USD Million)
  • 7.11. Non-alcoholic steatohepatitis (NASH)
    • 7.11.1. Global Human Microbiome Therapeutics Market, by Non-alcoholic steatohepatitis (NASH), by Region, 2016- 2027 (USD Million)
  • 7.12. Obesity
    • 7.12.1. Global Human Microbiome Therapeutics Market, by Obesity, by Region, 2016- 2027 (USD Million)
  • 7.13. Coeliac Disease
    • 7.13.1. Global Human Microbiome Therapeutics Market, by Coeliac Disease, by Region, 2016- 2027 (USD Million)

8. Human Microbiome Therapeutics Market Assessment by Approach

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. Global Human Microbiome Therapeutics Market, By Approach, 2015 - 2026 (USD Million)
  • 8.3. Small Molecule Therapies
    • 8.3.1. Global Human Microbiome Therapeutics Market, by Small Molecule Therapies, by Region, 2016- 2027 (USD Million)
  • 8.4. Single Strain Whole Bacteria
    • 8.4.1. Global Human Microbiome Therapeutics Market, by Single Strain Whole Bacteria, by Region, 2016- 2027 (USD Million)
  • 8.5. Microbial Consortia
    • 8.5.1. Global Human Microbiome Therapeutics Market, by Microbial Consortia, by Region, 2016- 2027 (USD Million)
  • 8.6. Genetically Modified Single Strain Bacteria
    • 8.6.1. Global Human Microbiome Therapeutics Market, by Genetically Modified Single Strain Bacteria, by Region, 2016- 2027 (USD Million)
  • 8.7. Phage Cocktail
    • 8.7.1. Global Human Microbiome Therapeutics Market, by Phage Cocktail, by Region, 2016- 2027 (USD Million)
  • 8.8. Microbial Ecosystems
    • 8.8.1. Global Human Microbiome Therapeutics Market, by Microbial Ecosystems, by Region, 2016- 2027 (USD Million)

9. Human Microbiome Therapeutics Market Assessment by Geography

  • 9.1. Key findings
  • 9.2. Introduction
    • 9.2.1. Human Microbiome Therapeutics Market Assessment, By Geography, 2016- 2027 (USD Million)
  • 9.3. Human Microbiome Therapeutics Market - North America
    • 9.3.1. North America: Human Microbiome Therapeutics Market, By Product, 2016- 2027 (USD Million)
    • 9.3.2. North America: Human Microbiome Therapeutics Market, By Therapeutic Area, 2016- 2027 (USD Million)
    • 9.3.3. North America: Human Microbiome Therapeutics Market, By Indication, 2016 - 2027 (USD Million)
    • 9.3.4. North America: Human Microbiome Therapeutics Market, By Approach, 2016- 2027 (USD Million)
    • 9.3.5. Human Microbiome Therapeutics Market - U.S.
      • 9.3.5.1. U.S.: Human Microbiome Therapeutics Market, By Product, 2016- 2027 (USD Million)
      • 9.3.5.2. U.S.: Human Microbiome Therapeutics Market, By Therapeutic Area, 2016- 2027 (USD Million)
      • 9.3.5.3. U.S.: Human Microbiome Therapeutics Market, By Indication, 2016- 2027 (USD Million)
      • 9.3.5.4. U.S.: Human Microbiome Therapeutics Market, By Approach, 2016- 2027 (USD Million)
    • 9.3.6. Human Microbiome Therapeutics Market - Canada
      • 9.3.6.1. Canada: Human Microbiome Therapeutics Market, By Product, 2016- 2027 (USD Million)
      • 9.3.6.2. Canada.: Human Microbiome Therapeutics Market, By Therapeutic Area, 2016- 2027 (USD Million)
      • 9.3.6.3. Canada: Human Microbiome Therapeutics Market, By Indication, 2016- 2027 (USD Million)
      • 9.3.6.4. Canada: Human Microbiome Therapeutics Market, By Approach, 2016- 2027 (USD Million)
  • 9.4. Human Microbiome Therapeutics Market - Europe
    • 9.4.1. Europe: Human Microbiome Therapeutics Market, By Product, 2016- 2027 (USD Million)
    • 9.4.2. Europe.: Human Microbiome Therapeutics Market, By Therapeutic Area, 2016- 2027 (USD Million)
    • 9.4.3. Europe: Human Microbiome Therapeutics Market, By Indication, 2016- 2027 (USD Million)
    • 9.4.4. Europe: Human Microbiome Therapeutics Market, By Approach, 2016- 2027 (USD Million)
    • 9.4.5. Human Microbiome Therapeutics Market - UK
      • 9.4.5.1. UK: Human Microbiome Therapeutics Market, By Product, 2016- 2027 (USD Million)
      • 9.4.5.2. UK.: Human Microbiome Therapeutics Market, By Therapeutic Area, 2016- 2027 (USD Million)
      • 9.4.5.3. UK: Human Microbiome Therapeutics Market, By Indication, 2016- 2027 (USD Million)
      • 9.4.5.4. UK: Human Microbiome Therapeutics Market, By Approach, 2016- 2027 (USD Million)
    • 9.4.6. Human Microbiome Therapeutics Market - France
      • 9.4.6.1. France: Human Microbiome Therapeutics Market, By Product, 2016- 2027 (USD Million)
      • 9.4.6.2. France.: Human Microbiome Therapeutics Market, By Therapeutic Area, 2016- 2027 (USD Million)
      • 9.4.6.3. France: Human Microbiome Therapeutics Market, By Indication, 2016- 2027 (USD Million)
      • 9.4.6.4. France: Human Microbiome Therapeutics Market, By Approach, 2016- 2027 (USD Million)
    • 9.4.7. Human Microbiome Therapeutics Market - Germany
      • 9.4.7.1. Germany: Human Microbiome Therapeutics Market, By Product, 2016- 2027 (USD Million)
      • 9.4.7.2. Germany.: Human Microbiome Therapeutics Market, By Therapeutic Area, 2016- 2027 (USD Million)
      • 9.4.7.3. Germany: Human Microbiome Therapeutics Market, By Indication, 2016- 2027 (USD Million)
      • 9.4.7.4. Germany: Human Microbiome Therapeutics Market, By Approach, 2016- 2027 (USD Million)
    • 9.4.8. Human Microbiome Therapeutics Market - Italy
      • 9.4.8.1. Italy: Human Microbiome Therapeutics Market, By Product, 2016- 2027 (USD Million)
      • 9.4.8.2. Italy.: Human Microbiome Therapeutics Market, By Therapeutic Area, 2016- 2027 (USD Million)
      • 9.4.8.3. Italy: Human Microbiome Therapeutics Market, By Indication, 2016- 2027 (USD Million)
      • 9.4.8.4. Italy: Human Microbiome Therapeutics Market, By Approach, 2016- 2027 (USD Million)
    • 9.4.9. 7.9.5 Human Microbiome Therapeutics Market - Netherlands
      • 9.4.9.1. Netherlands: Human Microbiome Therapeutics Market, By Product, 2016- 2027 (USD Million)
      • 9.4.9.2. Netherlands.: Human Microbiome Therapeutics Market, By Therapeutic Area, 2016- 2027 (USD Million)
      • 9.4.9.3. Netherlands: Human Microbiome Therapeutics Market, By Indication, 2016- 2027 (USD Million)
      • 9.4.9.4. Netherlands: Human Microbiome Therapeutics Market, By Approach, 2016- 2027 (USD Million)
    • 9.4.10. Human Microbiome Therapeutics Market - Spain
      • 9.4.10.1. Spain: Human Microbiome Therapeutics Market, By Product, 2016- 2027 (USD Million)
      • 9.4.10.2. Spain.: Human Microbiome Therapeutics Market, By Therapeutic Area, 2016- 2027 (USD Million)
      • 9.4.10.3. Spain: Human Microbiome Therapeutics Market, By Indication, 2016- 2027 (USD Million)
      • 9.4.10.4. Spain: Human Microbiome Therapeutics Market, By Approach, 2016- 2027 (USD Million)
    • 9.4.11. Human Microbiome Therapeutics Market - Austria
      • 9.4.11.1. Austria: Human Microbiome Therapeutics Market, By Product, 2016- 2027 (USD Million)
      • 9.4.11.2. Austria.: Human Microbiome Therapeutics Market, By Therapeutic Area, 2016- 2027 (USD Million)
      • 9.4.11.3. Austria: Human Microbiome Therapeutics Market, By Indication, 2016- 2027 (USD Million)
      • 9.4.11.4. Austria: Human Microbiome Therapeutics Market, By Approach, 2016- 2027 (USD Million)
  • 9.5. Human Microbiome Therapeutics Market - Asia-Pacific
    • 9.5.1. Asia Pacific: Human Microbiome Therapeutics Market, By Product, 2016- 2027 (USD Million)
    • 9.5.2. Asia Pacific.: Human Microbiome Therapeutics Market, By Therapeutic Area, 2016- 2027 (USD Million)
    • 9.5.3. Asia-pacific: Human Microbiome Therapeutics Market, By Indication, 2016- 2027 (USD Million)
    • 9.5.4. Asia-pacific: Human Microbiome Therapeutics Market, By Approach, 2016- 2027 (USD Million)
    • 9.5.5. Human Microbiome Therapeutics Market - China
      • 9.5.5.1. China: Human Microbiome Therapeutics Market, By Product, 2016- 2027 (USD Million)
      • 9.5.5.2. China.: Human Microbiome Therapeutics Market, By Therapeutic Area, 2016- 2027 (USD Million)
      • 9.5.5.3. China: Human Microbiome Therapeutics Market, By Indication, 2016- 2027 (USD Million)
      • 9.5.5.4. China: Human Microbiome Therapeutics Market, By Approach, 2016- 2027 (USD Million)
    • 9.5.6. Human Microbiome Therapeutics Market - India
      • 9.5.6.1. India: Human Microbiome Therapeutics Market, By Product, 2016- 2027 (USD Million)
      • 9.5.6.2. India.: Human Microbiome Therapeutics Market, By Therapeutic Area, 2016- 2027 (USD Million)
      • 9.5.6.3. India: Human Microbiome Therapeutics Market, By Indication, 2016- 2027 (USD Million)
      • 9.5.6.4. India: Human Microbiome Therapeutics Market, By Approach, 2016- 2027 (USD Million)
    • 9.5.7. Human Microbiome Therapeutics Market - Malaysia
      • 9.5.7.1. Malaysia: Human Microbiome Therapeutics Market, By Product, 2016- 2027 (USD Million)
      • 9.5.7.2. Malaysia.: Human Microbiome Therapeutics Market, By Therapeutic Area, 2016- 2027 (USD Million)
      • 9.5.7.3. Malaysia: Human Microbiome Therapeutics Market, By Indication, 2016- 2027 (USD Million)
      • 9.5.7.4. Malaysia: Human Microbiome Therapeutics Market, By Approach, 2016- 2027 (USD Million)
    • 9.5.8. Human Microbiome Therapeutics Market - Japan
      • 9.5.8.1. Japan: Human Microbiome Therapeutics Market, By Product, 2016- 2027 (USD Million)
      • 9.5.8.2. Japan: Human Microbiome Therapeutics Market, By Therapeutic Area, 2016- 2027 (USD Million)
      • 9.5.8.3. Japan: Human Microbiome Therapeutics Market, By Indication, 2016- 2027 (USD Million)
      • 9.5.8.4. Japan: Human Microbiome Therapeutics Market, By Approach, 2016- 2027 (USD Million)
    • 9.5.9. Human Microbiome Therapeutics Market - South Korea
      • 9.5.9.1. South Korea: Human Microbiome Therapeutics Market, By Product, 2016- 2027 (USD Million)
      • 9.5.9.2. South Korea.: Human Microbiome Therapeutics Market, By Therapeutic Area, 2016- 2027 (USD Million)
      • 9.5.9.3. South Korea: Human Microbiome Therapeutics Market, By Indication, 2016- 2027 (USD Million)
      • 9.5.9.4. South Korea: Human Microbiome Therapeutics Market, By Approach, 2016- 2027 (USD Million)
    • 9.5.10. Human Microbiome Therapeutics Market - Australia
      • 9.5.10.1. Australia: Human Microbiome Therapeutics Market, By Product, 2016- 2027 (USD Million)
      • 9.5.10.2. Australia.: Human Microbiome Therapeutics Market, By Therapeutic Area, 2016- 2027 (USD Million)
      • 9.5.10.3. Australia: Human Microbiome Therapeutics Market, By Indication, 2016- 2027 (USD Million)
      • 9.5.10.4. Australia: Human Microbiome Therapeutics Market, By Approach, 2016- 2027 (USD Million)
  • 9.6. Human Microbiome Therapeutics Market - Middle East & Africa
    • 9.6.1. Middle East & Africa: Human Microbiome Therapeutics Market, By Product, 2016- 2027 (USD Million)
    • 9.6.2. Middle East & Africa.: Human Microbiome Therapeutics Market, By Therapeutic Area, 2016- 2027 (USD Million)
    • 9.6.3. Middle East & Africa: Human Microbiome Therapeutics Market, By Indication, 2016- 2027 (USD Million)
    • 9.6.4. Middle East & Africa: Human Microbiome Therapeutics Market, By Approach, 2016- 2027 (USD Million)
    • 9.6.5. Human Microbiome Therapeutics Market - Saudi Arabia
      • 9.6.5.1. Saudi Arabia: Human Microbiome Therapeutics Market, By Product, 2016- 2027 (USD Million)
      • 9.6.5.2. Saudi Arabia.: Human Microbiome Therapeutics Market, By Therapeutic Area, 2016- 2027 (USD Million)
      • 9.6.5.3. Saudi Arabia: Human Microbiome Therapeutics Market, By Indication, 2016- 2027 (USD Million)
      • 9.6.5.4. Saudi Arabia: Human Microbiome Therapeutics Market, By Approach, 2016- 2027 (USD Million)
    • 9.6.6. Human Microbiome Therapeutics Market - UAE
      • 9.6.6.1. UAE: Human Microbiome Therapeutics Market, By Product, 2016- 2027 (USD Million)
      • 9.6.6.2. UAE.: Human Microbiome Therapeutics Market, By Therapeutic Area, 2016- 2027 (USD Million)
      • 9.6.6.3. UAE: Human Microbiome Therapeutics Market, By Indication, 2016- 2027 (USD Million)
      • 9.6.6.4. UAE: Human Microbiome Therapeutics Market, By Approach, 2016- 2027 (USD Million)
    • 9.6.7. Human Microbiome Therapeutics Market - Israel
      • 9.6.7.1. Israel: Human Microbiome Therapeutics Market, By Product, 2016- 2027 (USD Million)
      • 9.6.7.2. Israel.: Human Microbiome Therapeutics Market, By Therapeutic Area, 2016- 2027 (USD Million)
      • 9.6.7.3. Israel: Human Microbiome Therapeutics Market, By Indication, 2016- 2027 (USD Million)
      • 9.6.7.4. Israel: Human Microbiome Therapeutics Market, By Approach, 2016- 2027 (USD Million)
    • 9.6.8. Human Microbiome Therapeutics Market - South Africa
      • 9.6.8.1. South Africa: Human Microbiome Therapeutics Market, By Product, 2016- 2027 (USD Million)
      • 9.6.8.2. South Africa.: Human Microbiome Therapeutics Market, By Therapeutic Area, 2016- 2027 (USD Million)
      • 9.6.8.3. South Africa: Human Microbiome Therapeutics Market, By Indication, 2016- 2027 (USD Million)
      • 9.6.8.4. South Africa: Human Microbiome Therapeutics Market, By Approach, 2016- 2027 (USD Million)
  • 9.7. Human Microbiome Therapeutics Market - Latin America
    • 9.7.1. Latin America: Human Microbiome Therapeutics Market, By Product, 2016- 2027 (USD Million)
    • 9.7.2. Latin America.: Human Microbiome Therapeutics Market, By Therapeutic Area, 2016- 2027 (USD Million)
    • 9.7.3. Latin America: Human Microbiome Therapeutics Market, By Indication, 2016- 2027 (USD Million)
    • 9.7.4. Latin America: Human Microbiome Therapeutics Market, By Approach, 2016- 2027 (USD Million)
    • 9.7.5. Human Microbiome Therapeutics Market - Mexico
      • 9.7.5.1. Mexico: Human Microbiome Therapeutics Market, By Product, 2016- 2027 (USD Million)
      • 9.7.5.2. Mexico: Human Microbiome Therapeutics Market, By Therapeutic Area, 2016- 2027 (USD Million)
      • 9.7.5.3. Mexico: Human Microbiome Therapeutics Market, By Indication, 2016- 2027 (USD Million)
      • 9.7.5.4. Mexico: Human Microbiome Therapeutics Market, By Approach, 2016- 2027 (USD Million)
    • 9.7.6. Human Microbiome Therapeutics Market - Brazil
      • 9.7.6.1. Brazil: Human Microbiome Therapeutics Market, By Product, 2016- 2027 (USD Million)
      • 9.7.6.2. Brazil.: Human Microbiome Therapeutics Market, By Therapeutic Area, 2016- 2027 (USD Million)
      • 9.7.6.3. Brazil: Human Microbiome Therapeutics Market, By Indication, 2016- 2027 (USD Million)
      • 9.7.6.4. Brazil: Human Microbiome Therapeutics Market, By Approach, 2016- 2027 (USD Million)
    • 9.7.7. Human Microbiome Therapeutics Market - Argentina
      • 9.7.7.1. Argentina: Human Microbiome Therapeutics Market, By Product, 2016- 2027 (USD Million)
      • 9.7.7.2. Argentina.: Human Microbiome Therapeutics Market, By Therapeutic Area, 2016- 2027 (USD Million)
      • 9.7.7.3. Argentina: Human Microbiome Therapeutics Market, By Indication, 2016- 2027 (USD Million)
      • 9.7.7.4. Argentina: Human Microbiome Therapeutics Market, By Approach, 2016- 2027 (USD Million)

10. Competitive Landscape

  • 10.1. Expansion and Acquisition Analysis
    • 10.1.1. Expansion Analysis
    • 10.1.2. Acquisition Analysis
  • 10.2. Partnerships/Collaborations/Agreements/Exhibitions

11. Company Profiles

  • 11.1. Enterome Bioscience
    • 11.1.1. Company Overview
    • 11.1.2. Financial Performance
    • 11.1.3. Product Benchmarking
    • 11.1.4. Recent Development
  • 11.2. Seres Therapeutics
    • 11.2.1. Company Overview
    • 11.2.2. Financial Performance
    • 11.2.3. Product Benchmarking
    • 11.2.4. Recent Development
  • 11.3. 4D Pharma PLC
    • 11.3.1. Company Overview
    • 11.3.2. Financial Performance
    • 11.3.3. Product Benchmarking
    • 11.3.4. Recent Development
  • 11.4. Finch Therapeutics
    • 11.4.1. Company Overview
    • 11.4.2. Financial Performance
    • 11.4.3. Product Benchmarking
    • 11.4.4. Recent Development
  • 11.5. GNUbiotics Sciences
    • 11.5.1. Company Overview
    • 11.5.2. Financial Performance
    • 11.5.3. Product Benchmarking
    • 11.5.4. Recent Development
  • 11.6. 5QBD-Biotech
    • 11.6.1. Company Overview
    • 11.6.2. Financial Performance
    • 11.6.3. Product Benchmarking
    • 11.6.4. Recent Development
  • 11.7. Vedanta Biosciences
    • 11.7.1. Company Overview
    • 11.7.2. Financial Performance
    • 11.7.3. Product Benchmarking
    • 11.7.4. Recent Development
  • 11.8. Ferring Pharmaceuticals
    • 11.8.1. Company Overview
    • 11.8.2. Financial Performance
    • 11.8.3. Product Benchmarking
    • 11.8.4. Recent Development
  • 11.9. Evelo Biosciences
    • 11.9.1. Company Overview
    • 11.9.2. Financial Performance
    • 11.9.3. Product Benchmarking
    • 11.9.4. Recent Development
  • 11.10. Igen Biolab Group
    • 11.10.1. Company Overview
    • 11.10.2. Financial Performance
    • 11.10.3. Product Benchmarking
    • 11.10.4. Recent Development
  • 11.11. Embion Technologies
    • 11.11.1. Company Overview
    • 11.11.2. Financial Performance
    • 11.11.3. Product Benchmarking
    • 11.11.4. Recent Development